DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Sofosbuvir and Velpatasvir, Atc J05ap55 for the Period May 1, 2024 - April.... The project location is Germany and the tender is closing on 05 Mar 2026. The tender notice number is -, while the TOT Ref Number is 98975915.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Sofosbuvir and Velpatasvir, Atc J05ap55 for the Period May 1, 2024 - April...
Sign in with Google